Antibody molecules which bind CD45

US11692041B2 · kind B2 · utility

Assignee

• UCB BIOPHARMA SRL · BE

Inventors

• Helene Margaret Finney · Slough, GB
• Stephen Edward Rapecki · Slough, GB
• Kerry Louise Tyson · Slough, GB
• Michael John Wright · Slough, GB

Key dates

• Filing date: Jul 15, 2016
• Grant date: Jul 4, 2023
• Expiry date: May 10, 2038

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07K2317/90
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present disclosure relates to constructs, such as antibody molecules comprising a binding domain specific to CD45, said binding domain comprising SEQ ID NO: 1, 2, 3 and/or SEQ ID NO: 4, 5 and 6. The disclosure also extends to pharmaceutical compositions comprising said constructs and use of the constructs/compositions in treatment.